Evidence map›Paper›PMID 41039554›Full record

ArticleBMC health services research2025

Medication-related burden variation across chronic conditions: a population-based cross-sectional survey.

Heidi Mikkola, Emma Aarnio, Katri Hämeen-Anttila, Marja Airaksinen, Maarit Dimitrow, Leena Saastamoinen

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Heidi MikkolaFinnish Medicines Agency (Fimea), Helsinki, Finland. heidi.mikkola@fimea.fi.ORCID http://orcid.org/0009-0003-6880-6377
Emma AarnioSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0002-6555-7833
Katri Hämeen-AnttilaSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0002-3515-0792
Marja AiraksinenClinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-6077-5671
Maarit DimitrowClinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0009-0004-8199-0700
Leena SaastamoinenFinnish Medicines Agency (Fimea), Helsinki, Finland.ORCID http://orcid.org/0000-0002-0887-0137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedication therapy is an important healthcare intervention for patients with chronic conditions. Managing their own medication can place a burden known as medication-related burden (MRB) on the patients. The burden can vary among chronic conditions due to diverse medication and management needs. This study aimed to examine the variation in MRB across different chronic conditions in the adult general population.

methodsThis study was an online population-based cross-sectional survey conducted in 2021 representing Finnish adults aged 18-79 years. MRB was measured using a 13-item MRB instrument with a 5-point Likert scale, which is based on the 'Patients' lived experience with medicines' (PLEM) model. The instrument was divided into five dimensions: burden of medication routines; burden of medication characteristics; burden of adverse drug reactions; medication-related social burden; and healthcare-associated medication burden. The respondents were considered to have experienced MRB if they strongly agreed with at least one of the 13 items. Pearson's chi-square test was used for bivariate analyses between MRB and chronic conditions. Logistic regression analyses were performed to identify chronic conditions associated with MRB when adjusted for sociodemographic and health-related variables.

resultsOf the 2,081 respondents, 1,323 (63.6%) reported having at least one diagnosed chronic condition and using at least one prescription medication, thus forming the study population. Of them, 43.5% reported experiencing MRB. According to the multiple logistic regression model, diabetes (OR 1.77), heart disease (OR 1.53), rheumatic disease or other musculoskeletal disorders (OR 1.42), or other unspecified chronic conditions (OR 1.55) were associated with MRB (p < 0.05) when adjusted for demographic and health-related variables. The dimensions that contributed the most to MRB were the healthcare-associated medication burden (26.7%) and the burden of adverse drug reactions (21.5%).

conclusionsMRB is rather common among people with chronic conditions, the prevalence varying according to the conditions. MRB was associated with diabetes, heart disease, and rheumatic disease. Identifying chronic conditions that increase the likelihood of MRB enables allocation of healthcare resources and planning of interventions to patients with those specific illnesses.

Indexed as

Cost of IllnessDrug-Related Side Effects and Adverse ReactionsAdolescentAdultAgedChronic DiseaseCross-Sectional StudiesFemaleFinlandHumansMaleMiddle AgedSurveys and QuestionnairesYoung AdultAdult populationChronic conditionMedication-related burdenMedication self-managementPatient perspectiveSurvey

Identifiers

PMID41039554
PMCPMC12492796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.